NEW YORK (GenomeWeb News) – The National Institute of Drug Abuse will fund researchers studying how genetic variation affects drug abuse and drug addition, and resistance for drugs commonly abused, such as psychostimulants, opiates, nicotine, and marijuana.
 
In an effort to better understand abuse phenotypes by studying underlying genetic factors, NIDA plans to spend $2 million to fund between eight and ten grantees over the next two years in the “Behavioral Pharmacology and Genetics: Translating Individual Differences” program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.